Active, not recruiting
HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma
NCT06187961
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China